Check out our most popular compounded medications! Get Started
This Dexamethasone Sodium Phosphate 1.6 mg/mL and Lidocaine HCl 8 mg/mL solution is a specialized liquid formulation designed for use in iontophoresis therapy. By applying an electric current, this solution facilitates the transdermal delivery of medication through the skin, providing targeted treatment.
It is primarily used for managing conditions such as localized inflammation, pain management, and musculoskeletal disorders.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This specialized liquid formulation combines Dexamethasone Sodium Phosphate 1.6 mg/mL and Lidocaine HCl 8 mg/mL for use in iontophoresis therapy. Iontophoresis utilizes a mild electric current to enhance the transdermal delivery of medications, allowing for targeted treatment directly through the skin.
Dexamethasone Sodium Phosphate is a potent corticosteroid with strong anti-inflammatory and immunosuppressant properties. It works by inhibiting the body's inflammatory responses, thereby reducing swelling, redness, and pain associated with various inflammatory conditions.
Lidocaine HCl is a local anesthetic that temporarily numbs the area where it is applied. It works by blocking nerve signals in the body, providing fast-acting pain relief and reducing discomfort during and after the treatment.
The combination of Dexamethasone and Lidocaine in this iontophoresis solution offers a synergistic effect, delivering both anti-inflammatory medication and local anesthetic directly to the affected area. This dual-action approach not only reduces inflammation but also provides immediate pain relief, enhancing patient comfort.
This formulation is particularly beneficial for treating localized inflammatory conditions such as tendinitis, bursitis, epicondylitis, plantar fasciitis, and other musculoskeletal disorders. It may also be used in managing localized neuropathic pain and various soft tissue injuries where reducing inflammation and pain is desired.
During iontophoresis therapy, the solution is applied to the skin over the treatment area, and electrodes are attached. A gentle electrical current is then applied, which helps propel the ionized form of the medications through the skin barrier into the underlying tissues. This non-invasive method facilitates higher local concentrations of the medication with minimal systemic exposure.
Patients undergoing this treatment may experience mild skin irritation or redness at the application site, which is usually transient. It is important to inform your healthcare provider of any skin conditions, allergies, or if you are pregnant or breastfeeding. Prescribers should assess the patient's medical history for any contraindications to corticosteroids or local anesthetics.
By utilizing this iontophoresis solution, patients can benefit from targeted therapy that addresses both inflammation and pain directly at the source, potentially accelerating recovery and improving quality of life. If you have any questions about this treatment or its suitability for you, please reach out to us.
When using the Dexamethasone Sodium Phosphate 1.6 mg/mL/Lidocaine HCl 8 mg/mL Solution for iontophoresis, it is crucial to consider potential drug interactions that may affect the efficacy and safety of the treatment. Dexamethasone, a corticosteroid, and lidocaine, a local anesthetic, each have their own interaction profiles that must be carefully managed to ensure optimal therapeutic outcomes.
Dexamethasone may interact with a variety of medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and certain vaccines. Concurrent use of NSAIDs can increase the risk of gastrointestinal bleeding, while anticoagulants may have altered effects due to dexamethasone's influence on blood clotting factors. Live vaccines should be avoided, as corticosteroids can suppress the immune response, potentially leading to inadequate vaccine efficacy or increased risk of infection.
Lidocaine, on the other hand, can interact with antiarrhythmic drugs, beta-blockers, and other local anesthetics. The combination with antiarrhythmic drugs may enhance cardiac effects, leading to potential arrhythmias. Beta-blockers can increase the plasma concentration of lidocaine, heightening the risk of systemic toxicity. Additionally, using multiple local anesthetics concurrently can lead to additive toxic effects, particularly concerning the central nervous system and cardiovascular system.
For patients undergoing iontophoresis therapy with this formulation, it is essential to disclose all current medications, including over-the-counter drugs and supplements, to the healthcare provider. This information will help in assessing potential interactions and adjusting treatment plans accordingly. Prescribers should carefully evaluate the patient's medication history and consider any necessary adjustments to avoid adverse interactions.
Furthermore, patients with pre-existing conditions such as cardiovascular disorders, liver or kidney impairment, or a history of hypersensitivity to corticosteroids or local anesthetics should be closely monitored. These conditions may exacerbate the effects of drug interactions or increase the risk of adverse reactions.
If you have any questions or concerns regarding the use of this formulation and potential drug interactions, please reach out to us for further guidance and support. Our team of compounding pharmacists at Bayview Pharmacy is here to assist you in ensuring appropriate treatment.
Dexamethasone Sodium Phosphate 1.6 mg/mL and Lidocaine HCl 8 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed to enhance the delivery of medication through the skin using a technique known as iontophoresis. This method employs a mild electric current to drive charged drug molecules across the dermal barrier, allowing for targeted and efficient treatment of specific conditions. The formulation combines the anti-inflammatory properties of dexamethasone sodium phosphate with the local anesthetic effects of lidocaine hydrochloride.
Dexamethasone sodium phosphate is a potent corticosteroid that works by inhibiting the release of substances in the body that cause inflammation. When delivered via iontophoresis, dexamethasone can be directed precisely to the site of inflammation, reducing swelling, redness, and pain associated with various inflammatory conditions. This targeted approach minimizes systemic exposure and potential side effects, making it a preferred option for localized treatment.
Lidocaine hydrochloride, on the other hand, is a well-known local anesthetic that blocks nerve signals in the body, providing immediate pain relief. By combining lidocaine with dexamethasone in this formulation, patients can experience rapid alleviation of pain while simultaneously addressing the underlying inflammatory process. This dual-action approach is particularly beneficial for conditions such as tendonitis, bursitis, and other musculoskeletal disorders where both pain and inflammation are present.
The iontophoresis process involves placing electrodes on the skin, with one electrode containing the medication solution. When the electric current is applied, the charged drug molecules are repelled from the electrode and driven into the skin. This method not only enhances the penetration of the medication but also allows for precise control over the dosage and duration of treatment. The non-invasive nature of iontophoresis makes it an attractive option for patients who may be apprehensive about injections or systemic medications.
It can be tailored to the specific needs of the patient, with adjustments in the current intensity and duration of treatment to optimize therapeutic outcomes. Additionally, the combination of dexamethasone and lidocaine in a single formulation simplifies the treatment regimen, reducing the need for multiple medications and enhancing patient compliance.
Patients undergoing iontophoresis with this formulation can expect a reduction in pain and inflammation, leading to improved mobility and quality of life. The treatment is generally well-tolerated, with minimal side effects due to the localized delivery of the medication. However, as with any medical treatment, it is important for patients to communicate with their healthcare provider about any concerns or adverse reactions they may experience.
If you have any questions about this formulation or its use in iontophoresis therapy, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your treatment options.
This specialized liquid formulation is used in iontophoresis therapy to facilitate the transdermal delivery of medication through the skin. It is primarily used for targeted treatment in pain management or localized drug delivery.
Iontophoresis therapy uses an electric current to enhance the penetration of the Dexamethasone Sodium Phosphate and Lidocaine HCl solution through the skin, allowing for effective and localized treatment.
This formulation is commonly used to treat conditions that require localized pain management or anti-inflammatory effects, such as tendonitis, bursitis, or other musculoskeletal disorders.
While generally safe, this formulation should be used under the guidance of a healthcare professional. Patients with certain conditions or allergies should consult their doctor before use.
The frequency of iontophoresis therapy sessions should be determined by a healthcare provider, based on the specific condition being treated and the patient's response to therapy.
Possible side effects may include skin irritation or redness at the site of application. If any severe reactions occur, it is important to contact a healthcare professional immediately.
It is important to discuss all current medications with a healthcare provider to ensure there are no interactions. The provider can offer guidance on the safe use of this formulation with other treatments.
This solution should be stored at room temperature, away from direct sunlight and moisture. It should be kept out of reach of children and pets.
If a session is missed, consult with your healthcare provider to determine the best course of action. Do not attempt to double the next session to make up for the missed one.
Individuals with known allergies to any components of the formulation, or those with certain medical conditions, should avoid using this solution. A healthcare provider can offer specific advice based on individual health needs.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
